The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.
As we mark the 29th World AIDS Day, Sarah Hand says that with enough commitment, political will and funding we have the tools to achieve UNAIDS’ ambitious fast track targets – but only if we recognise the need for a new approach to HIV prevention.
Drug policy based on prohibition hasn't worked. It's time to build on the success of partial-decriminalisation models with an emphasis on health and human rights, says new report.
We count down the top five things that everybody should know about HIV - from AIDS, to testing, to symptoms, to treatment.
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.
Heightened concerns regarding the link between the hormonal contraceptive, Depo-Provera, and the risk of HIV acquisition in women after new systematic review released.
UNAIDS has raised the alarm on new HIV infections among adults and the need to step up prevention efforts with 1.9 million adults becoming infected with HIV globally each year since 2010.
More than 20 organisations representing the voices of people who use drugs and LGBT communities have been banned by their countries from attending next month’s UN General Assembly High-Level Meeting on Ending AIDS.
Two recent studies show that vaginal rings are effective at cutting HIV infection rates among women. But the overall effectiveness was not significant - less than a third of infections were prevented.